デフォルト表紙
市場調査レポート
商品コード
993542

ヘルスケアにおける流通の世界市場

Healthcare Distribution

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 298 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ヘルスケアにおける流通の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 298 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のヘルスケアにおける流通の市場規模は、分析期間(2020年~2027年)に5.3%のCAGRで成長する見通しで、2020年の7億9,180万米ドルから、2027年には11億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つである製薬は、分析期間中に5.9%のCAGRで成長し、4億9,060万米ドルに達すると予測されています。

当レポートは、世界のヘルスケアにおける流通市場について調査しており、市場シェア、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • AmerisourceBergen Corporation
  • Attain Med, Inc.
  • Cardinal Health, Inc.
  • Curascript Specialty Distribution
  • Dakota Drug
  • FFF Enterprises, Inc.
  • Henry Schein Inc.
  • McKesson Corporation
  • Medline Industries
  • Morris & Dickson Co., L.L.C.
  • Mutual Drug
  • Owens & Minor, Inc.
  • Patterson Companies Inc.,
  • Rochester Drug Cooperative, Inc.,
  • Smith Drug Company

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

IV. 競合

  • 企業プロファイル:35社
目次
Product Code: MCP21926

Abstract:

Global Healthcare Distribution Market to Reach US$3.2 Trillion by the Year 2027

Amid the COVID-19 crisis, the global market for Healthcare Distribution estimated at US$876.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Trillion by 2027, growing at a CAGR of 20.2% over the analysis period 2020-2027.Pharmaceutical, one of the segments analyzed in the report, is projected to grow at a 19.9% CAGR to reach US$1.3 Trillion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biopharmaceutical segment is readjusted to a revised 22.4% CAGR for the next 7-year period. This segment currently accounts for a 33.7% share of the global Healthcare Distribution market.

The U.S. Accounts for Over 34.8% of Global Market Size in 2020, While China is Forecast to Grow at a 22.2% CAGR for the Period of 2020-2027

The Healthcare Distribution market in the U.S. is estimated at US$305 Billion in the year 2020. The country currently accounts for a 34.81% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$561.3 Billion in the year 2027 trailing a CAGR of 22.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 18.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 20.5% CAGR while Rest of European market (as defined in the study) will reach US$561.3 Billion by the year 2027.

Medical Devices Segment Corners a 24% Share in 2020

In the global Medical Devices segment, USA, Canada, Japan, China and Europe will drive the 17.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$169.4 Billion in the year 2020 will reach a projected size of US$510.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$398.3 Billion by the year 2027, while Latin America will expand at a 17.4% CAGR through the analysis period.

Select Competitors (Total 61 Featured) -

  • AmerisourceBergen Corporation
  • Attain Med, Inc.
  • Cardinal Health, Inc.
  • Curascript Specialty Distribution
  • Dakota Drug
  • FFF Enterprises, Inc.
  • Henry Schein Inc.
  • McKesson Corporation
  • Medline Industries
  • Morris & Dickson Co., L.L.C.
  • Mutual Drug
  • Owens & Minor, Inc.
  • Patterson Companies Inc.,
  • Rochester Drug Cooperative, Inc.,
  • Smith Drug Company

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • The Race Between the Virus & Vaccines Intensifies. Amidst this Chaotic Battle, Where is the World Economy Headed in 2021?
    • EXHIBIT 1: How Fast the World is Vaccinated Will Determine How Soon the Pandemic Will End: Global Number of Annual COVID-19 Vaccine Doses (In Million) for Years 2020 through 2025 by Geographic Region/Country
    • Progress on Vaccinations, Why Should Businesses Care?
    • These are Times When Questions Abound & Answers Are Few
    • With IMF's Upward Revision of Global GDP Forecasts for 2021, Most Companies Are Bullish About a Global Economic Comeback.
    • EXHIBIT 2: A Strong 2021 Economic Rebound Based On Pent-Up Demand Comes as a Relief for Suffering Industries & Markets: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • EXHIBIT 3: Easing Unemployment Levels in 2021 Although Moderate Will Infuse Hope for Industries Reliant on Consumer Discretionary Incomes: Global Number of Unemployed People (In Million) for Years 2017, 2019, 2020, and 2022
    • A Retrospective Review of Year 2020 as the Worst Year in Humanity's History that Left the World in Shambles & Industries and Markets Upended
    • How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What's the New Normal?
    • The Biggest & Worst Ever Public Health Crisis in Human History Creates a Mixed Bag of Challenges & Opportunities for the Healthcare Industry
    • EXHIBIT 4: With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
    • Clinical Diagnostic Laboratories Work Overtime to Manage Giant Waves of COVID Infection Testing Flowing In
    • EXHIBIT 5: Global Clinical Diagnostics Market Reset & Trajectory - Growth Outlook (In %) For Years 2019 Through 2025
    • The Pandemic Triggers Shift in Consumer Behaviour & Engagement With Healthcare Technologies & Services
    • Healthcare Industry Pushed to Adopt Digital Technologies & Innovate to Save Lives Amid the Crisis
    • EXHIBIT 6: Digital Health Technologies Poised to Break New Grounds Post Pandemic: Global Opportunity in Digital Health (In US$ Billion) for Years 2020, 2022, 2024 and 2026
    • How COVID-19 Outbreak Sent the Healthcare Supply Chain Into a Tailspin
    • EXHIBIT 7: Unprecedented Losses Sustained in the Supply Chain Bodes Well for Integration of Emerging Technologies like Blockchain to Enhance Resilience & Reliability: Global Losses in Supply Chain as a % of Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA) in the Year 2020
    • EXHIBIT 8: Far-Flung Supply Chains of the Pharma Industry Cannot be Consolidated Easily & Abruptly, But the Winds of Change Blown by COVID-19 Can Be Felt: Global Number of Plants Registered with the U.S. to Supply Active Pharmaceutical Ingredients as of the Year 2020
    • Healthcare Supply Chain Management Storms Into the Spotlight to Address Disruptions Posed by the Crisis
    • EXHIBIT 9: With Smart Management of Supply Chains Being the Need of the Hour, Healthcare Supply Chain Management to Reach New Highs: Global Opportunity in Healthcare Supply Chain Management (In US$ Million) for Years 2020, 2022, 2024, 2026
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • The Importance & Current State Of Drug Distribution Worldwide: A Review
    • Special Focus on India, a Promising Global Pharma Powerhouse
    • Substandard Drugs, an Urgent Challenge in the Supply Chain that Begs to be Addressed
    • Pharmaceutical Thefts & Counterfeiting, A Persistent Challenge in Distribution That Eludes Resolution
    • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
    • Storming Into the Spotlight Is the Use of Blockchain in Fighting Counterfeiting of Drugs
    • EXHIBIT 10: Rising Incidence of Counterfeiting in the Pharmaceutical Industry Pushes Up the Urgency to Leverage the Security Benefits Promised by Blockchain: Global Number of Pharmaceutical Counterfeiting Incidents for Years 2000, 2005, 2010, 2015, 2019 & 2022
    • Serialization Emerges as an Another Weapon in the Arsenal to Battle Counterfeiting
    • Rising Healthcare Costs Drives Attractiveness of e-Pharmacies
    • EXHIBIT 11: Here's How Healthcare Costs Are Outstripping Global GDP: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Social Distancing Amid the COVID-19 Pandemic Accelerates the Viability & Indispensability of e-Pharmacies, Fast Forwarding Growth by Over 2 Years
    • EXHIBIT 12: Global ePharmacy Sales Breakdown (In %) by OTC Drugs & RX Drugs As of the Year 2021
    • Aging Population, Rising Prevalence of Chronic Diseases & Ensuing Demand for Drugs & Medical Equipment Rank as Major Drivers of Growth in the Market
    • EXHIBIT 13: Aging Population Steps-Up the Burden On Healthcare Systems Including Distribution: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 14: Rising Prevalence of Chronic Diseases Amplifies Demand for Pharmaceutical Drugs & Distribution: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Robust Demand for Pharmaceutical Drugs Drives Growth in the Market
    • Pharmaceutical Contract Manufacturing, a Barometer of the Growing Demand & Production of Drugs
    • EXHIBIT 15: More Drugs Being Manufactured Means More Drugs in Distribution: Global Opportunity for Pharmaceutical Contract Manufacturing (In US$ Billion) for Years 2020, 2022, 2024, and 2026
    • Artificial Intelligence to Revolutionize Pharmaceutical Retailing
    • As the World Ramps Up Production of COVID-19 Vaccines, Distribution Emerges Into the Spotlight
    • As Mass Vaccination Drives Kick-in, Challenges in Covid-19 Vaccine Distribution Begin to Surface
    • A Review of Vaccine Distribution Approach in the US
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Biopharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 22: USA Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 23: USA Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: USA 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 28: Canada Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Canada Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: Canada 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 34: Japan Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Japan Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Japan 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 40: China Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: China Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: China 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 46: Europe Current & Future Analysis for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 47: Europe Historic Review for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Europe 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 55: France Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: France 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 58: France Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 61: Germany Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Germany 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 64: Germany Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 67: Italy Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Italy 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 70: Italy Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 73: UK Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: UK 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 76: UK Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 79: Spain Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Spain Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: Spain 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 82: Spain Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Spain Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Spain 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 85: Russia Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Russia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Russia 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 88: Russia Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Russia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Russia 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 91: Rest of Europe Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of Europe 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 94: Rest of Europe Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of Europe 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 97: Asia-Pacific Current & Future Analysis for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 98: Asia-Pacific Historic Review for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Asia-Pacific 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 100: Asia-Pacific Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Asia-Pacific 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 106: Australia Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Australia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Australia 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 109: Australia Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Australia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Australia 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 112: India Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: India Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: India 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 115: India Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: India Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: India 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 118: South Korea Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: South Korea Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: South Korea 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 121: South Korea Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: South Korea Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: South Korea 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Rest of Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: Rest of Asia-Pacific 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 130: Latin America Current & Future Analysis for Healthcare Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 131: Latin America Historic Review for Healthcare Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: Latin America 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 133: Latin America Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Latin America Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: Latin America 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 136: Latin America Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 139: Argentina Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Argentina Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 141: Argentina 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 142: Argentina Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Argentina Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 144: Argentina 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 145: Brazil Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Brazil Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 147: Brazil 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 148: Brazil Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Brazil Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 150: Brazil 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 151: Mexico Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Mexico Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 153: Mexico 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 154: Mexico Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Mexico Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 156: Mexico 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 157: Rest of Latin America Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Rest of Latin America Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 159: Rest of Latin America 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 160: Rest of Latin America Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Rest of Latin America Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 162: Rest of Latin America 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 163: Middle East Current & Future Analysis for Healthcare Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 164: Middle East Historic Review for Healthcare Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 165: Middle East 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 166: Middle East Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Middle East Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 168: Middle East 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 169: Middle East Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 172: Iran Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Iran Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 174: Iran 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 175: Iran Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Iran Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 177: Iran 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 178: Israel Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Israel Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 180: Israel 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 181: Israel Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Israel Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 183: Israel 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 184: Saudi Arabia Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Saudi Arabia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 186: Saudi Arabia 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 187: Saudi Arabia Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Saudi Arabia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 189: Saudi Arabia 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 190: UAE Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 191: UAE Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 192: UAE 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 193: UAE Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 194: UAE Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 195: UAE 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 196: Rest of Middle East Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Rest of Middle East Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 198: Rest of Middle East 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 199: Rest of Middle East Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Rest of Middle East Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 201: Rest of Middle East 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 202: Africa Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Africa Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 204: Africa 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2020 & 2027
    • TABLE 205: Africa Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Africa Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 207: Africa 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 61